Pyc Therapeutics
Clinical trials sponsored by Pyc Therapeutics, explained in plain language.
-
New eye drug shows promise for rare Blindness-Causing mutation
Disease control CompletedThis early-stage study tested a new drug called VP-001, given as an injection into the eye, in 17 adults with a rare inherited eye disease caused by a PRPF31 gene mutation. The main goal was to check if the drug is safe and tolerable. The study is complete, and results will help …
Phase: PHASE1 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Jun 17, 2026 01:26 UTC
-
New eye injection shows promise for rare Blindness-Causing gene mutation
Disease control CompletedThis early-stage study tested the safety of a new drug called VP-001, given as an injection into the eye, for people with a rare genetic eye disease (PRPF31 mutation) that causes vision loss. Six participants aged 12 and older received multiple doses. The main goal was to check f…
Phase: PHASE1 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC